Since in malignant pleural mesothelioma C/EBP-β LIP transcriptionally activates CRT [27], one of the main ICD effector, we next investigated whether the absent induction of C/EBP-β LIP upon doxorubicin treatment also reduced the pro-immunogenic effects of the anthracycline in resistant TNBC cells. Here, CALR is linked to malignant pleural mesothelioma.